Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disorders

Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disorders

US Patent 11447571 · Granted Sep 20, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cance2025
Kappa myeloma antigen chimeric antigen receptors and uses thereof2022
Method for treating multiple myeloma2010
Method for treating multiple myeloma2009
Method for treating multiple myeloma2008